Jane Street Group, LLC Enlivex Therapeutics Ltd. Transaction History
Jane Street Group, LLC
- $481 Billion
- Q2 2025
A detailed history of Jane Street Group, LLC transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 61,052 shares of ENLV stock, worth $95,851. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,052
Previous 80,759
24.4%
Holding current value
$95,851
Previous $78,000
12.82%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ENLV
# of Institutions
25Shares Held
2.57MCall Options Held
79.1KPut Options Held
0-
Armistice Capital, LLC New York, NY1.41MShares$2.22 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny612KShares$961,1540.0% of portfolio
-
Morgan Stanley New York, NY219KShares$344,0630.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny168KShares$264,3750.0% of portfolio
-
Sigma Investment Counselors Inc28KShares$43,9600.0% of portfolio
About Enlivex Therapeutics Ltd.
- Ticker ENLV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,403,200
- Market Cap $28.9M
- Description
- Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...